CD274 and neoplasm: reported that when WT and Ythdf1 −/− tumor-bearing melanoma cells mice were treated with an anti-PD-L1 antibody, all Ythdf1−/− mice showed complete tumor suppression, whereas only 40% of the control group showed regression (154).